The results also highlight strong overlap of PNPLA3 in the genetics of NAFLD and other liver pathologies and metabolic traits in the population, indicating a spectrum of conditions. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.